Premier EBITDA Margin 2012-2024 | PINC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Premier (PINC) over the last 10 years. The current EBITDA margin for Premier as of December 31, 2024 is .
| Premier EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-12-31 | $1.29B | $0.07B | 5.60% |
| 2024-09-30 | $1.33B | $0.23B | 17.42% |
| 2024-06-30 | $1.35B | $0.26B | 19.08% |
| 2024-03-31 | $1.23B | $0.21B | 16.80% |
| 2023-12-31 | $1.21B | $0.35B | 28.74% |
| 2023-09-30 | $1.29B | $0.38B | 29.05% |
| 2023-06-30 | $1.34B | $0.38B | 28.14% |
| 2023-03-31 | $1.34B | $0.40B | 29.62% |
| 2022-12-31 | $1.36B | $0.39B | 28.61% |
| 2022-09-30 | $1.38B | $0.38B | 27.28% |
| 2022-06-30 | $1.43B | $0.39B | 27.15% |
| 2022-03-31 | $1.57B | $0.40B | 25.29% |
| 2021-12-31 | $1.70B | $0.41B | 23.88% |
| 2021-09-30 | $1.74B | $0.39B | 22.64% |
| 2021-06-30 | $1.72B | $0.38B | 21.95% |
| 2021-03-31 | $1.58B | $0.39B | 24.51% |
| 2020-12-31 | $1.45B | $0.43B | 29.97% |
| 2020-09-30 | $1.35B | $0.49B | 36.65% |
| 2020-06-30 | $1.30B | $0.53B | 40.54% |
| 2020-03-31 | $1.27B | $0.54B | 42.73% |
| 2019-12-31 | $1.24B | $0.53B | 42.37% |
| 2019-09-30 | $1.23B | $0.50B | 40.91% |
| 2019-06-30 | $1.22B | $0.51B | 41.71% |
| 2019-03-31 | $0.86B | $0.52B | 60.65% |
| 2018-12-31 | $0.98B | $0.53B | 53.81% |
| 2018-09-30 | $1.09B | $0.69B | 63.54% |
| 2018-06-30 | $1.18B | $0.66B | 56.00% |
| 2018-03-31 | $1.24B | $0.65B | 52.01% |
| 2017-12-31 | $1.20B | $0.62B | 52.05% |
| 2017-09-30 | $1.15B | $0.43B | 37.29% |
| 2017-06-30 | $1.07B | $0.42B | 39.55% |
| 2017-03-31 | $1.35B | $0.38B | 28.09% |
| 2016-12-31 | $1.27B | $0.37B | 29.01% |
| 2016-09-30 | $1.21B | $0.36B | 29.96% |
| 2016-06-30 | $1.16B | $0.35B | 30.18% |
| 2016-03-31 | $1.13B | $0.36B | 31.44% |
| 2015-12-31 | $1.09B | $0.34B | 31.23% |
| 2015-09-30 | $1.05B | $0.33B | 31.36% |
| 2015-06-30 | $1.01B | $0.32B | 31.78% |
| 2015-03-31 | $0.98B | $0.31B | 32.10% |
| 2014-12-31 | $0.94B | $0.31B | 33.01% |
| 2014-09-30 | $0.90B | $0.30B | 33.48% |
| 2014-06-30 | $0.91B | $0.34B | 37.54% |
| 2014-03-31 | $0.92B | $0.38B | 41.77% |
| 2013-12-31 | $0.92B | $0.41B | 44.81% |
| 2013-09-30 | $0.91B | $0.43B | 47.15% |
| 2013-06-30 | $0.87B | $0.40B | 46.32% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.877B | $1.346B |
| Premier, Inc. operates as a healthcare alliance. The company brings together hospitals, health systems, physicians and other healthcare providers primarily in the United States. It also maintains clinical, financial and outcomes databases. Premier, Inc. is headquartered in Charlotte, North Carolina. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $136.657B | 25.63 |
| Elevance Health (ELV) | United States | $88.114B | 11.37 |
| CVS Health (CVS) | United States | $76.496B | 9.51 |
| Cencora (COR) | United States | $55.428B | 19.28 |
| DiDi Global (DIDIY) | China | $22.215B | 33.71 |
| Natera (NTRA) | United States | $20.400B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.620B | 13.36 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.158B | 0.00 |
| CochLear (CHEOY) | Australia | $11.298B | 0.00 |
| Doximity (DOCS) | United States | $10.912B | 50.83 |
| Revvity (RVTY) | United States | $10.655B | 18.34 |
| ICON (ICLR) | Ireland | $10.552B | 9.81 |
| Viatris (VTRS) | United States | $10.317B | 3.54 |
| Avantor (AVTR) | United States | $8.750B | 12.71 |
| Medpace Holdings (MEDP) | United States | $8.519B | 22.63 |
| HealthEquity (HQY) | United States | $8.446B | 41.55 |
| Sonic Healthcare (SKHHY) | Australia | $8.201B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.822B | 13.37 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $4.185B | 38.74 |
| Bausch + Lomb (BLCO) | Canada | $4.171B | 24.58 |
| Sotera Health (SHC) | United States | $3.616B | 20.55 |
| Surgery Partners (SGRY) | United States | $3.029B | 39.39 |
| Alignment Healthcare (ALHC) | United States | $2.948B | 0.00 |
| Concentras Parent (CON) | United States | $2.925B | 16.90 |
| Organon (OGN) | United States | $2.280B | 2.42 |
| Ardent Health Partners (ARDT) | United States | $2.179B | 9.29 |
| Progyny (PGNY) | United States | $1.882B | 41.42 |
| GeneDx Holdings (WGS) | United States | $1.815B | 69.90 |
| PACS (PACS) | United States | $1.625B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.432B | 28.64 |
| Pediatrix Medical (MD) | United States | $1.278B | 9.73 |
| Teladoc Health (TDOC) | United States | $1.272B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.059B | 0.00 | |
| Agilon Health (AGL) | United States | $1.056B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| Nutex Health (NUTX) | United States | $0.967B | 14.61 |
| CareDx (CDNA) | United States | $0.896B | 14.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.857B | 8.02 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| Embecta (EMBC) | United States | $0.681B | 4.59 |
| InnovAge Holding (INNV) | United States | $0.570B | 0.00 |
| Enhabit (EHAB) | United States | $0.545B | 44.83 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 13.63 |
| Sonida Senior Living (SNDA) | United States | $0.493B | 0.00 |
| LifeMD (LFMD) | United States | $0.439B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.367B | 0.00 |
| SBC Medicals (SBC) | United States | $0.361B | 0.00 |
| Oncology Institute (TOI) | United States | $0.230B | 0.00 |
| Beauty Health (SKIN) | United States | $0.217B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.204B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Sera Prognostics (SERA) | United States | $0.090B | 0.00 |
| KindlyMD (KDLY) | United States | $0.083B | 0.00 |
| So-Young (SY) | China | $0.083B | 0.00 |
| OncoCyte (OCX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.049B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.035B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Biodesix (BDSX) | United States | $0.032B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |